Chembio Diagnostics Short Interest Ratio and Short Volume

+0.05 (+1.79 %)
(As of 07/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume6.41 million shs
Average Volume30.31 million shs
Market Capitalization$57.51 million
P/E RatioN/A
Dividend YieldN/A

Chembio Diagnostics (NASDAQ:CEMI) Short Interest Data

Current Short Volume1,280,000 shares
Previous Short Volume1,390,000 shares
Change Vs. Previous Month-7.91%
Dollar Volume Sold Short$3.12 million
Short Interest Ratio / Days to Cover0.1
Last Record DateJuly, 15 2021
Outstanding Shares20,250,000 shares
Float Size18,580,000 shares
Short Percent of Float6.89%
Today's Trading Volume6,406,314 shares
Average Trading Volume30,308,420 shares
Today's Volume Vs. Average-78.86%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Chembio Diagnostics ?

Sign up to receive the latest short interest report for Chembio Diagnostics and its competitors with MarketBeat's FREE newsletter.

Chembio Diagnostics (NASDAQ:CEMI) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20211,280,000 shares $3.12 million -7.9%6.9%0.1 $2.44
6/30/20211,390,000 shares $4.13 million -26.1%7.5%2.6 $2.97
6/15/20211,880,000 shares $5.90 million -16.8%10.2%0.4 $3.14
5/28/20212,260,000 shares $7.21 million +12.4%12.2%0.5 $3.19
5/14/20212,010,000 shares $6.47 million -9.9%N/A0.4 $3.22
4/30/20212,230,000 shares $9.12 million -8.6%N/A0.4 $4.09
4/15/20212,440,000 shares $9.44 million +23.2%N/A0.5 $3.87
3/31/20211,980,000 shares $6.73 million No ChangeN/A0.4 $3.40
3/15/20211,980,000 shares $8.69 million -9.6%N/A2.1 $4.39
2/26/20212,190,000 shares $12.37 million -30.7%N/A1.9 $5.65
2/12/20213,160,000 shares $22.56 million -13.0%N/A2.2 $7.14
1/29/20213,630,000 shares $23.27 million -3.2%N/A2.4 $6.41
1/15/20213,750,000 shares $22.09 million -1.3%N/A2.4 $5.89
12/31/20203,800,000 shares $18.54 million -1.8%N/A2.5 $4.88
12/15/20203,870,000 shares $21.52 million +7.2%N/A2 $5.56
11/30/20203,610,000 shares $19.57 million -12.8%N/A1.7 $5.42
11/15/20204,140,000 shares $18.13 million -13.9%N/A2.1 $4.38
10/30/20204,810,000 shares $23.57 million +5.3%N/A1.9 $4.90
10/15/20204,570,000 shares $21.80 million +1.8%N/A1.4 $4.77
9/30/20204,490,000 shares $21.82 million +4.7%N/A1 $4.86
9/15/20204,290,000 shares $17.85 million -10.3%N/A0.8 $4.16
8/31/20204,780,000 shares $19.60 million -9.8%N/A0.8 $4.10
8/14/20205,300,000 shares $27.77 million -1.1%N/A0.9 $5.24
7/31/20205,360,000 shares $29.64 million +32.7%N/A1.1 $5.53
7/15/20204,040,000 shares $20.60 million +31.6%N/A0.9 $5.10

Chembio Diagnostics (NASDAQ:CEMI) Short Interest FAQ

speech bubbles
speech bubbles

What is Chembio Diagnostics' current short interest?

Short interest is the volume of Chembio Diagnostics shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 1,280,000 shares of CEMI short. 6.89% of Chembio Diagnostics' shares are currently sold short. Learn More on Chembio Diagnostics' current short interest.

What is a good short interest percentage for Chembio Diagnostics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.89% of Chembio Diagnostics' floating shares are currently sold short.

Is Chembio Diagnostics' short interest increasing or decreasing?

Chembio Diagnostics saw a drop in short interest during the month of July. As of July 15th, there was short interest totaling 1,280,000 shares, a drop of 7.9% from the previous total of 1,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Chembio Diagnostics' float size?

Chembio Diagnostics currently has issued a total of 20,250,000 shares. Some of Chembio Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Chembio Diagnostics currently has a public float of 18,580,000 shares.

How does Chembio Diagnostics' short interest compare to its competitors?

6.89% of Chembio Diagnostics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Chembio Diagnostics: Sol-Gel Technologies Ltd. (2.07%), BELLUS Health Inc. (1.82%), Kala Pharmaceuticals, Inc. (14.99%), CTI BioPharma Corp. (2.68%), CorMedix Inc. (6.64%), Pieris Pharmaceuticals, Inc. (5.75%), Trevena, Inc. (11.69%), Spruce Biosciences, Inc. (6.38%), BCTG Acquisition Corp. (0.04%), and Galera Therapeutics, Inc. (2.52%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.55 billion), Square, Inc. ($7.47 billion), S&P Global Inc. ($7.40 billion), Analog Devices, Inc. ($6.82 billion), Aon plc ($5.98 billion), Charter Communications, Inc. ($5.10 billion), Wayfair Inc. ($4.38 billion), AMC Entertainment Holdings, Inc. ($2.87 billion), Teladoc Health, Inc. ($2.55 billion), and Nuance Communications, Inc. ($2.41 billion). View all of the most shorted stocks.

What does it mean to sell short Chembio Diagnostics stock?

Short selling CEMI is an investing strategy that aims to generate trading profit from Chembio Diagnostics as its price is falling. Chembio Diagnostics' stock is trading up $0.05 today. To short Chembio Diagnostics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Chembio Diagnostics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Chembio Diagnostics?

A short squeeze for Chembio Diagnostics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CEMI, which in turn drives the price of the stock up even further.

How often is Chembio Diagnostics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CEMI, twice per month. The most recent reporting period available is July, 15 2021.

This page was last updated on 7/31/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.